These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 8690044

  • 21. [Biological modulation of IL-1 activity: role and development of its natural inhibitor IL-1Ra].
    Dayer JM.
    Reumatismo; 2004; 56(1 Suppl 1):3-8. PubMed ID: 15201935
    [Abstract] [Full Text] [Related]

  • 22. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M, Zwicker M, Villiger PM.
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [Abstract] [Full Text] [Related]

  • 23. Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes.
    Seitz M, Zwicker M, Loetscher P.
    Arthritis Rheum; 1998 Nov; 41(11):2032-8. PubMed ID: 9811059
    [Abstract] [Full Text] [Related]

  • 24. Interleukin-1 and tumor necrosis factor antagonists attenuate ethanol-induced inhibition of bone formation in a rat model of distraction osteogenesis.
    Perrien DS, Brown EC, Fletcher TW, Irby DJ, Aronson J, Gao GG, Skinner RA, Hogue WR, Feige U, Suva LJ, Ronis MJ, Badger TM, Lumpkin CK.
    J Pharmacol Exp Ther; 2002 Dec; 303(3):904-8. PubMed ID: 12438508
    [Abstract] [Full Text] [Related]

  • 25. Differential regulation of metalloproteinase production, proliferation and chemotaxis of human lung fibroblasts by PDGF, interleukin-1beta and TNF-alpha.
    Sasaki M, Kashima M, Ito T, Watanabe A, Izumiyama N, Sano M, Kagaya M, Shioya T, Miura M.
    Mediators Inflamm; 2000 Dec; 9(3-4):155-60. PubMed ID: 11132772
    [Abstract] [Full Text] [Related]

  • 26. Interleukin-1beta and tumor necrosis factor-alpha produce distinct, time-dependent patterns of acute arthritis in the rat knee.
    Bolon B, Campagnuolo G, Zhu L, Duryea D, Zack D, Feige U.
    Vet Pathol; 2004 May; 41(3):235-43. PubMed ID: 15133172
    [Abstract] [Full Text] [Related]

  • 27. Interleukin 1 autocrine growth system in human multiple myeloma.
    Nagata K, Tanaka Y, Oda S, Yamashita U, Eto S.
    Jpn J Clin Oncol; 1991 Feb; 21(1):22-9. PubMed ID: 2067118
    [Abstract] [Full Text] [Related]

  • 28. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity.
    Pederson L, Winding B, Foged NT, Spelsberg TC, Oursler MJ.
    Cancer Res; 1999 Nov 15; 59(22):5849-55. PubMed ID: 10582709
    [Abstract] [Full Text] [Related]

  • 29. Actions of recombinant interleukin 1, interleukin 2, and interferon-gamma on bone resorption in vitro.
    Gowen M, Mundy GR.
    J Immunol; 1986 Apr 01; 136(7):2478-82. PubMed ID: 3081643
    [Abstract] [Full Text] [Related]

  • 30. The combination of tumor necrosis factor alpha blockade with interleukin-1 and interleukin-17 blockade is more effective for controlling synovial inflammation and bone resorption in an ex vivo model.
    Chabaud M, Miossec P.
    Arthritis Rheum; 2001 Jun 01; 44(6):1293-303. PubMed ID: 11407688
    [Abstract] [Full Text] [Related]

  • 31. An in vitro osteoclast-forming assay to measure myeloma cell-derived osteoclast-activating factors.
    Zannettino AC, Farrugia AN, To LB, Atkins GJ.
    Methods Mol Med; 2005 Jun 01; 113():245-56. PubMed ID: 15968108
    [Abstract] [Full Text] [Related]

  • 32. Rosiglitazone induces interleukin-1 receptor antagonist in interleukin-1beta-stimulated rat synovial fibroblasts via a peroxisome proliferator-activated receptor beta/delta-dependent mechanism.
    Moulin D, Bianchi A, Boyault S, Sebillaud S, Koufany M, Francois M, Netter P, Jouzeau JY, Terlain B.
    Arthritis Rheum; 2005 Mar 01; 52(3):759-69. PubMed ID: 15751073
    [Abstract] [Full Text] [Related]

  • 33. Interleukin-4, interleukin-10, and interleukin-1-receptor antagonist but not transforming growth factor-beta induce ramification and reduce adhesion molecule expression of rat microglial cells.
    Wirjatijasa F, Dehghani F, Blaheta RA, Korf HW, Hailer NP.
    J Neurosci Res; 2002 Jun 01; 68(5):579-87. PubMed ID: 12111847
    [Abstract] [Full Text] [Related]

  • 34. Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow.
    Yamashita K, Iwasaki T, Tsujimura T, Sugihara A, Yamada N, Ueda H, Okamura H, Futani H, Maruo S, Terada N.
    Oncol Rep; 2002 Jun 01; 9(6):1237-44. PubMed ID: 12375027
    [Abstract] [Full Text] [Related]

  • 35. Analysis of the inflammatory cytokine network among TNF alpha, IL-1 beta, IL-1 receptor antagonist, and IL-8 in LPS-induced rabbit arthritis.
    Matsukawa A, Yoshimura T, Miyamoto K, Ohkawara S, Yoshinaga M.
    Lab Invest; 1997 May 01; 76(5):629-38. PubMed ID: 9166282
    [Abstract] [Full Text] [Related]

  • 36. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis.
    Nakahara H, Song J, Sugimoto M, Hagihara K, Kishimoto T, Yoshizaki K, Nishimoto N.
    Arthritis Rheum; 2003 Jun 01; 48(6):1521-9. PubMed ID: 12794819
    [Abstract] [Full Text] [Related]

  • 37. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP, Malyak M, Smith MF, Whisenand TD, Slack JL, Sims JE, Giri JG, Dower SK.
    J Immunol; 1994 Nov 15; 153(10):4766-74. PubMed ID: 7963543
    [Abstract] [Full Text] [Related]

  • 38. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist.
    Chole RA, Faddis BT, Tinling SP.
    J Bone Miner Res; 1995 Feb 15; 10(2):281-4. PubMed ID: 7754808
    [Abstract] [Full Text] [Related]

  • 39. Production of interleukin-1 by bone marrow myeloma cells.
    Cozzolino F, Torcia M, Aldinucci D, Rubartelli A, Miliani A, Shaw AR, Lansdorp PM, Di Guglielmo R.
    Blood; 1989 Jul 15; 74(1):380-7. PubMed ID: 2665838
    [Abstract] [Full Text] [Related]

  • 40. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells.
    Jourdan M, Tarte K, Legouffe E, Brochier J, Rossi JF, Klein B.
    Eur Cytokine Netw; 1999 Mar 15; 10(1):65-70. PubMed ID: 10210775
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.